Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.
D000328:Adult; D001692:Biological Transport; D001798:Blood Proteins / Q000032:analysis; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis* / Q000134:cerebrospinal fluid; D007278:Injections, Spinal; D007525:Isoelectric Focusing; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077555:Methylprednisolone Acetate; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology
D001798:Blood Proteins; D002556:Cerebrospinal Fluid Proteins; D007074:Immunoglobulin G; D000077555:Methylprednisolone Acetate; D008775:Methylprednisolone